The overexpression of cyclo-oxygenase-2 in chronic periodontitis

Journal of the American Dental Association

Volumn 134, Issue 7, 2003, Pages 861-867

  Zhang, Fan ^a   Engebretson, Steven P ^b   Morton, Rakhi S ^c   Cavanaugh Jr , Paul F ^d   Subbaramaiah, Kotha ^a   Dannenberg, Andrew J ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b New York Presbyterian Hospital   (United States)

^c Procter and Gamble Co ^*

^d PROCTER AND GAMBLE COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; PROTEIN; TUMOR NECROSIS FACTOR ALPHA; INTERLEUKIN 1; ISOENZYME; MEMBRANE PROTEIN; PEROXIDASE; PROSTAGLANDIN SYNTHASE; PTGS2 PROTEIN, HUMAN;

ADULT; ALVEOLAR BONE; ARTICLE; BIOCHEMISTRY; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EPITHELIUM CELL; GINGIVAL BIOPSY; GINGIVITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; OSTEOLYSIS; PERIODONTITIS; PROTEIN EXPRESSION; RADIOGRAPHY; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DRUG EFFECT; ENZYMOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; GINGIVA; MACROPHAGE; MALE; PROSPECTIVE STUDY;

ADULT; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; CYCLOOXYGENASE 2; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GINGIVA; GINGIVAL CREVICULAR FLUID; GINGIVITIS; HUMANS; INTERLEUKIN-1; ISOENZYMES; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MEMBRANE PROTEINS; PERIODONTITIS; PEROXIDASES; PROSPECTIVE STUDIES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0142089751     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.2003.0284     Document Type: Article

References (37)

1. Bartold PM, Walsh LJ, Narayanan AS. Molecular and cell biology of the gingiva. Periodontology 2000;24:28-55.
2. 2 secretion as a determinant of periodontal disease expression. J Periodontol 1993;64:432-44.
3. Offenbacher S, Odle BM, Van Dyke TE. The use of crevicular fluid prostaglandin E2 levels as a predictor of periodontal attachment loss. J Periodont Res 1986;21:101-12.
4. 2 on macrophages and osteoclasts in cultured fetal long bones. Cell Tissue Res 1980;207:341-6.
5. Williams RC, Jeffcoat MK, Kaplan ML, Goldhaber P, Johnson HG, Wechter WJ. Flurbiprofen: a potent inhibitor of alveolar bone resorption in beagles. Science 1985;227:640-2.
6. Jeffcoat MK, Page R, Reddy M, et al. Use of digital radiography to demonstrate the potential of naproxen as an adjunct in the treatment of rapidly progressive periodontitis. J Periodont Res 1991;26:415-21.
7. Reddy MS, Palcanis KG, Barnett ML, Haigh S, Charles CH, Jeffcoat MK. Efficacy of meclofenamate sodium (MECLOMEN) in the treatment of rapidly progressive periodontitis. J Clin Periodontol 1993;20:635-40.
8. Jeffcoat MK, Reddy MS, Haigh S, et al. A comparison of topical ketorolac, systemic flurbiprofen, and placebo for the inhibition of bone loss in adult periodontitis. J Periodontol 1995;66:329-38.
9. Smith WL, Garavito RM, DeWitt DL. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 1996;271:33157-160.
10. DuBois RN, Awad J, Morrow J, Roberts LJ, Bishop PR. Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-α and phorbol ester. J Clin Invest 1994;93:493-8.
11. Subbaramaiah K, Telang N, Ramonetti JT, et al. Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. Cancer Res 1996;56:4424-9.
12. Rhee SH, Hwang D. Murine TOLL-like receptor 4 confers lipopolysaccharide responsiveness as determined by activation of NFκB and expression of the inducible cyclooxygenase. J Biol Chem 2000;275:34035-40.
13. Crofford LJ, Wilder RL, Ristimaki AP, et al. Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. J Clin Invest 1994;93:1095-101.
14. Singer II, Kawka DW, Schloemann S, Tessner T, Riehl T, Stenson WF. Cyclooxygenase-2 is induced in colonic epithelial cells in inflammatory bowel disease. Gastroenterology 1998;115:297-306.
15. Cavanaugh PF Jr., McDonald JS, Pavelic L, Limardi RJ, Gluckman JL, Pavelic ZP. Immunohistochemical localization of prostaglandin H synthase isoenzyme proteins in the gingival tissue of patients with periodontitis. Inflammopharmacology 1995;3:109-19.
16. Morton RS, Dongari-Bagtzoglou AI. Cyclooxygenase-2 is upregulated in inflamed gingival tissues. J Periodontol 2001;72:461-9.
17. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6.
18. Löe H, Silness J. Periodontal disease in pregnancy, I: prevalence and severity. Acta Odontol Scand 1963;21:533-51.
19. Engebretson SP, Grbic JT, Singer RE, Lamster IB. GCF IL-1β profiles in periodontal disease. J Clin Periodontol 2002;29:48-53.
20. Engebretson SP, Lamster IB, Herrera-Abreu M, et al. The influence of interleukin gene polymorphism on expression of interleukin-1β and tumor necrosis factor-α in periodontal tissue and gingival crevicular fluid. J Periodontol 1999;70:567-73.
21. Mestre JR, Subbaramaiah K, Sacks PG, et al. Retinoids suppress phorbol ester-mediated induction of cyclooxygenase-2. Cancer Res 1997;57:1081-5.
22. Fujita J, Mestre JR, Zeldis JB, Subbaramaiah K, Dannenberg AJ. Thalidomide and its analogues inhibit lipopolysaccharide-mediated induction of cyclooxygenase-2. Clin Cancer Res 2001;7:3349-55.
23. Chan G, Boyle JO, Yang EK, et al. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res 1999;59:991-4.
24. Cavanaugh PF Jr., Meredith MP, Buchanan W, Doyle MJ, Reddy MS, Jeffcoat MK. Coordinate production of PGE2 and IL-1β in the gingival crevicular fluid of adults with periodontitis: its relationship to alveolar bone loss and disruption by twice daily treatment with ketorolac tromethamine oral rinse. J Periodont Res 1998;33(2):75-82.
25. Ohzeki K, Yamaguchi M, Shimizu N, Abiko Y. Effect of cellular aging on the induction of cyclooxygenase-2 by mechanical stress in human periodontal ligament cells. Mech Ageing Dev 1999;108:151-63.
26. Kim HJ, Kim KW, Yu BP, Chung HY. The effect of age on cyclooxygenase-2 gene expression: NF-κB activation and IκBα degradation. Free Radic Biol Med 2000;28:683-92.
27. 2 and interleukin-1beta production from old rat periodontal ligament cells subjected to mechanical stress. J Gerontol A Biol Sci Med Sci 2000;55:B489-95.
28. Williams RC, Jeffcoat MK, Howell TH, et al. Altering the progression of human alveolar bone loss with the non-steroidal anti-inflammatory drug flurbiprofen. J Periodontol 1989;60:485-90.
29. Kelm GR, Buchanan W, Meredith M, et al. Evaluation of ketorolac concentrations in plasma and gingival crevicular fluid following topical treatment with oral rinses and dentifrices. J Pharm Sci 1996;85:842-7.
30. Cavanaugh PF Jr., Meredith MP, Gerlach RW. The use of ketorolac tromethamine oral rinse for the treatment of periodontitis in adults. Inflammopharmacology 1998;5:204-5.
31. Vioxx prescribing information. Available at: "www.vioxx.com". Accessed May 19, 2003.
32. Celebrex prescribing information. Available at: "www.celebrex. com". Accessed May 19, 2003.
33. Langman MJ, Jensen DM, Watson DJ, et al. Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs. JAMA 1999;282:1929-33.
34. Fitzgerald GA, Patrono C. The COXIBS, selective inhibitors of cyclooxygenase-2. N Engl J Med 2001;345:433-42.
35. Shimizu N, Ozawa Y, Yamaguchi M, Goseki T, Ohzeki K, Abiko Y. Induction of COX-2 expression by mechanical tension force in human periodontal ligament cells. J Periodontol 1998;69:670-7.
36. 4 analogues inhibit leukocyte recruitment to Porphyromonas gingivalis: a role for cyclooxygenase-2 and lipoxins in periodontal disease. Biochemistry 2000;39:4761-8.
37. 2 production in human gingival fibroblasts stimulated with interleukin-1β and epidermal growth factor. Biochem Biophys Res Comm 1999;257:528-32.